Overview

StahistRx Phase 2, Five-arm, Parallel Group, Active vs Active, Double-blind Study

Status:
Unknown status
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
This active vs active comparative trial will evaluate the safety and efficacy of incremental doses of atropine in combination with pseudoephedrine 120 mg/chlorpheniramine 8 mg in adult patients with a history of seasonal allergic rhinitis. Hypotheses are defined by total nasal symptom scores (TNSS) recorded by subjects in diaries where efficacy will be established by statistical significance where p < 0.05.
Phase:
Phase 2
Details
Lead Sponsor:
Magna Pharmaceuticals, Inc.
Treatments:
Atropine
Chlorpheniramine
Ephedrine
Pseudoephedrine